SMN2 and proximal spinal muscular atrophy: SMN protein in humans is obtained from two highly similar genes, SMN1 and SMN2. Patients with SMA show reduced levels of SMN protein due to insufficient compensation of protein expression by SMN2. Without treatment and in its most severe forms, SMA leads to muscle atrophy, weakness, paralysis, and premature death.